09-1-2727 Citric ACid and Certain Citrate Salts U.S. producer ques

Information collections for import injury investigations (producers, importers, purchasers, and foreign producer questionnaires and institution notices for 5-year reviews)

citric acid us Producer (6)

Citric Acid and Certain Citrate Salts

OMB: 3117-0016

Document [pdf]
Download: pdf | pdf
OMB No. 3117-0016/USITC No. 09-1-2727; Expiration Date: 6/30/11
(No response is required if currently valid OMB control number is not displayed)

U.S. PRODUCERS’ QUESTIONNAIRE
CITRIC ACID AND CERTAIN CITRATE SALTS FROM CANADA AND CHINA

This questionnaire must be received by the Commission by no later than February 9, 2009
See page 4 of the Instruction Booklet for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its countervailing duty/antidumping investigations concerning citric acid and certain citrate salts from
Canada and China (Inv. Nos. 701-TA-456 and 731-TA-1151-1152 (Final)). The information requested in the
questionnaire is requested under the authority of the Tariff Act of 1930, title VII. This report is mandatory and failure to
reply as directed can result in a subpoena or other order to compel the submission of records or information in your
possession (19 U.S.C. § 1333(a)).

Name of firm
Address
State

City

Zip Code

World Wide Web address
Has your firm produced citric acid or certain citrate salts (as defined in the instruction booklet) at any time since
January 1, 2006?

NO

(Sign the certification below and promptly return only this page of the questionnaire to the Commission)

YES

(Read the instruction booklet carefully, complete all parts of the questionnaire, and return the entire
questionnaire to the Commission so as to be received by the date indicated above)

CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my knowledge
and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout these investigations in any other import-injury investigations conducted
by the Commission on the same or similar merchandise.
I acknowledge that information submitted in this questionnaire response and throughout these investigations may be used by the
Commission, its employees, and contract personnel who are acting in the capacity of Commission employees, for developing or
maintaining the records of these investigations or related proceedings for which this information is submitted, or in internal audits
and investigations relating to the programs and operations of the Commission pursuant to 5 U.S.C. Appendix 3. I understand that
all contract personnel will sign non-disclosure agreements.

Name of Authorized Official

Title of Authorized Official

Date

Signature

Phone: (
Fax ( )

E-mail address

)

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 2

PART I.—GENERAL INFORMATION
The questions in this questionnaire have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to average 50 hours per response,
including the time for reviewing instructions, searching existing data sources, gathering the data needed,
and completing and reviewing the questionnaire. Send comments regarding the accuracy of this burden
estimate or any other aspect of this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade Commission, 500 E Street, SW,
Washington, DC 20436.
I-1a.

Please report below the actual number of hours required and the cost to your firm of preparing the
reply to this questionnaire and completing the form.
hours

dollars

I-1b.

We are interested in any comments you may have for improving this questionnaire in general or
the clarity of specific questions. Please attach such comments to your response or send them to
the above address.

I-2.

Provide the name and address of establishment(s) covered by this questionnaire (see page 3 of the
instruction booklet for reporting guidelines). If your firm is publicly traded, please specify the
stock exchange and trading symbol.

I-3.

Do you support or oppose the petition?
Canada
Support

Oppose

Take no position

China
Support

Oppose

Take no position

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 3

PART I.--GENERAL INFORMATION--Continued
I-4.

Is your firm owned, in whole or in part, by any other firm?
No

Firm name

I-5.

Address

Extent of
ownership

Does your firm have any related firms, either domestic or foreign, which are engaged in
importing citric acid or certain citrate salts from Canada or China into the United States or which
are engaged in exporting citric acid or certain citrate salts from Canada or China to the United
States?
No
Firm name

I-6.

Yes--List the following information.

Yes--List the following information.
Address

Affiliation

Does your firm have any related firms, either domestic or foreign, which are engaged in the
production of citric acid or certain citrate salts?
No
Firm name

Yes--List the following information.
Address

Affiliation

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 4

PART II.--TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Chris Cassise (202-708-5408),
[email protected]). Supply all data requested on a calendar-year basis.
II-1.

Who should be contacted regarding the requested trade and related information?
Company contact:
Name and title
(
)
Phone number

II-2a.

Has your firm experienced any plant openings, relocations, expansions, acquisitions,
consolidations, closures, or prolonged shutdowns because of strikes, equipment failure, energy
disruptions, or other reasons; or any other change in the character of your operations or
organization relating to the production of citric acid or certain citrate salts since January 1, 2006?
No

II-2b.

Yes--Supply details as to the time, nature, and significance of such changes.

Has your firm experienced any curtailment of production because of shortages of raw materials
needed for the production of citric acid or certain citrate salts since January 1, 2006?
No

II-3.

E-mail address

Yes--Supply details of the curtailment of production.

Does your firm produce other products on the same equipment and machinery used in the
production of citric acid or certain citrate salts?
No

Yes--List the following information.

Basis for allocation of capacity data (e.g., sales):
Products produced on same equipment and share of total production in 2008 (in percent):
Product
Citric acid
Sodium citrate
Potassium citrate

Percent

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 5

PART II.--TRADE AND RELATED INFORMATION--Continued
II-4.

Please describe the constraint(s) that set the limit(s) on your production capacity and your ability
to shift production capacity between products.

II-5.

Does your firm produce other products using the same production and related workers employed
to produce citric acid or certain citrate salts?
No

Yes--List the following information.

Basis for allocation of capacity data (e.g., sales):
Products produced using the same workers and share of total production in 2008 (in percent):
Product

Percent

Citric acid
Sodium citrate
Potassium citrate

II-6.

Since January 1, 2006, has your firm been involved in a toll agreement (see definition in the
instruction booklet) regarding the production of citric acid or certain citrate salts?
No

II-7.

.

Does your firm produce citric acid or certain citrate salts in a foreign trade zone (FTZ)?
No

II-8.

Yes--Name firm(s):

Yes--Identify FTZ(s):

Since January 1, 2006, has your firm imported citric acid or certain citrate salts?
No

Yes--COMPLETE AND RETURN A U.S. IMPORTERS’
QUESTIONNAIRE

.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 6

PART II.--TRADE AND RELATED INFORMATION--Continued
II-9a.

Citric Acid and Certain Citrate Salts. Report your firm’s production capacity, production,
shipments, inventories, and employment related to the production of citric acid and certain citrate
salts in your U.S. establishment(s) during the specified periods. (See definitions in the instruction
booklet.) Please note that tables II-9b, II-9c, and II-9d are subsets of and should equal table II-9a.
Quantity (in 1,000 dry pounds) and value (in $1,000)
Calendar years
Item

2006

2007

2008

1

Average production capacity (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a
different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data
using that basis for 2006, 2007, and 2008 below:
3

Identify your principal export markets:
.
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period
inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?
4

Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 7

PART II.--TRADE AND RELATED INFORMATION--Continued
II-9b.

Citric Acid. Report your firm’s production capacity, production, shipments, inventories, and
employment related to the production of citric acid in your U.S. establishment(s) during the
specified periods. (See definitions in the instruction booklet.)
Quantity (in 1,000 dry pounds) and value (in $1,000)
Calendar years
Item

2006

2007

2008

1

Average production capacity (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internally consumed to produce-Sodium citrate
Quantity of internal consumption
Value2 of internal consumption
Potassium citrate
Quantity of internal consumption
Value2 of internal consumption
Other products (________________)
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per
year. Please describe the methodology used to calculate production capacity, and explain any changes in reported capacity (use additional
pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a different basis for
valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data using that basis for 2006, 2007, and
2008 below:

3

Identify your principal export markets:
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period inventories,
plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?

.

4

Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 8

PART II.--TRADE AND RELATED INFORMATION--Continued
II-9c. Sodium Citrate. Report your firm’s production capacity, production, shipments, inventories, and
employment related to the production of sodium citrate in your U.S. establishment(s) during the specified
periods. (See definitions in the instruction booklet.)
Quantity (in 1,000 dry pounds) and value (in $1,000)
Calendar years
Item

2006

2007

2008

1

Average production capacity (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a
different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data
using that basis for 2006, 2007, and 2008 below:
3

Identify your principal export markets:
.
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period
inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?
4

Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 9

PART II.--TRADE AND RELATED INFORMATION--Continued
II-9d.

Potassium Citrate. Report your firm’s production capacity, production, shipments, inventories,
and employment related to the production of potassium citrate in your U.S. establishment(s)
during the specified periods. (See definitions in the instruction booklet.)
Quantity (in 1,000 dry pounds) and value (in $1,000)
Calendar years
Item

2006

2007

2008

1

Average production capacity (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a
different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data
using that basis for 2006, 2007, and 2008 below:
3

Identify your principal export markets:
.
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period
inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?
4

Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 10

PART II.--TRADE AND RELATED INFORMATION--Continued
II-10. If you reported transfers to related firms in question II-9, please indicate the nature of the
relationship between your firm and the related firms (e.g., joint venture, wholly owned subsidiary),
whether the transfers were priced at market value or by a non-market formula, whether your firm retained
marketing rights to all transfers, and whether the related firms also processed inputs from sources other
than your firm.

II-11.

Other than direct imports, has your firm otherwise purchased citric acid or certain citrate salts
since January 1, 2006? (See definitions in the instruction booklet.)
Yes--Report such purchases below for the specified periods.1

No

(Quantity in 1,000 dry pounds, value in $1,000)
Calendar years
Item

2006

2007

2008

PURCHASES FROM U.S. IMPORTERS2
OF PRODUCT FROM-Canada:
Quantity
Value
China:
Quantity
Value
All other countries:
Quantity
Value
PURCHASES FROM DOMESTIC
2
PRODUCERS:
Quantity
Value
PURCHASES FROM OTHER SOURCES:2
Quantity
Value
1

2

Please indicate your reasons for purchasing this product. If your reasons differ by source, please elaborate.

Please list the name of the firm(s) from which you purchased this product. If your suppliers differ by source,
please identify the source for each listed supplier.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 11

PART II.--TRADE AND RELATED INFORMATION--Continued
II-12.

End Use Market Segments.--Please report what volume (in 1,000 dry pounds) of your 2008 U.S.
commercial shipments were used to produce products in each of the end-use market segments
listed below. (Provide this information if you know the end use of your firm’s U.S. commercial
shipments; estimate, if possible.)
Market Segment

Estimated 2008 shipments
(1,000 dry pounds)

Food and Beverage
Soft Drinks (carbonated beverages sold as a liquid)
Other Beverages
Total Beverage
Food
Subtotal, Food and Beverage
Industrial
Household detergents and cleaners
Other Industrial
Subtotal, Industrial
Pharmaceutical
Beauty and oral hygiene/cosmetics
Other Pharmaceutical
Subtotal, Pharmaceutical
Other__________________________________
Unknown
Total
II-13.

II-14.

Of your firm’s reported 2008 U.S. commercial shipments, what percentage of the quantity
consisted of citric acid or certain citrate salts in the following forms:
Anhydrous _____%

Monohydrate ____%

Solution ____%

Other (specify___________________) ____%.

Since January 1, 2006, has your firm produced monosodium citrate in the United States?
No

Yes—Report the quantity in (1,000 dry pounds) of your 2008 U.S. production
of that product.
________________________ 1,000 dry pounds

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 12

PART II.--TRADE AND RELATED INFORMATION--Continued
II-15. COMPARABILITY OF CITRIC ACID, SODIUM CITRATE, AND POTASSIUM
CITRATE.–Since January 1, 2006, has your firm produced more than one of the following: citric acid,
sodium citrate, or potassium citrate?
No

Yes--Please describe the differences and similarities between citric acid,
sodium citrate, and potassium citrate with respect to the following
factors:

(a) Characteristics and uses:

(b) Interchangeability:

(c) Manufacturing processes:

(d) Channels of distribution:

(e) Customer and producer perceptions:

(f) Price:

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 13

PART III.--FINANCIAL INFORMATION
Address questions on this part of the questionnaire to Justin Jee (202-205-3186, [email protected]).
III-1.

Who should be contacted regarding the requested financial information?
Company contact:
Name and title
(
)
Phone number

III-2.

E-mail address

Briefly describe your financial accounting system.
A.

When does your fiscal year end (month and day)?
If your fiscal year changed during the period examined, explain below:

B.1.

Describe the lowest level of operations (e.g., plant, division, company-wide) for
which financial statements are prepared that include subject merchandise:

2.
3.

4.

Does your firm prepare profit/loss statements for the subject merchandise:
Yes
No
How often did your firm (or parent company) prepare financial statements
(including annual reports, 10Ks)? Please check relevant items below.
Audited,
unaudited,
annual reports,
10Ks,
10 Qs,
Monthly,
quarterly,
semi-annually,
annually
Accounting basis:
GAAP,
cash,
tax, or
other comprehensive
(specify)

Note: The Commission may request that your company submit copies of its financial statements,
including internal profit-and-loss statements for the division or product group that includes citric
acid and certain citrate salts, as well as those statements and worksheets used to compile data for
your firm’s questionnaire response.

III-3.

Briefly describe your cost accounting system (e.g., standard cost, job order cost, etc.).

III-4.

Briefly describe your allocation basis, if any, for COGS, SG&A, and interest expense and other
income and expenses.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 14

PART III.--FINANCIAL INFORMATION--Continued
III-5.

Other products.--Please list any other products you produced in the facilities in which you
produced citric acid or certain citrate salts, and provide the share of net sales accounted for by
these other products in calendar year 2008:
Products

III-6.

Share of sales

Please list your firm’s products that used the raw material corn as an input and provide the share
of net sales accounted for by these products in the 2007 and 2008 calendar years.
Share of sales
2007
2008

Products
Citric acid
Citrate salts
Ethanol
Other (please specify)
Other (please specify)
III-7.

Does your firm receive inputs (raw materials, labor, energy, or any other services) used in the
production of citric acid or certain citrate salts from any related firm?
Yes—Continue to question III-8 below.

III-8.

No--Continue to question III-11 below.

In the space provided below, identify the inputs related to the production of citric acid or certain
citrate salts that your firm receives from related parties whose financial statements are
consolidated with the financial statements of your firm.
Input

Related party

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 15

PART III.--FINANCIAL INFORMATION--Continued
III-9.

With respect to the related companies identified in response to question III-7 above, are their
financial statements consolidated with your firm’s financial statements? (In other words, are
profits or losses arising from intercompany transactions eliminated?)
Yes—Continue to question III-9 below.

No--Continue to question III-10 below.

III-10. All intercompany profit on inputs purchased from related parties that is eliminated pursuant to
formal financial statement consolidation should also be eliminated from the costs reported to the
Commission in question III-11 (i.e., costs reported in question III-11, to the extent that they
reflect inputs purchased from related parties, should only reflect the related party’s cost and not
include an associated profit component). Reasonable methods for determining and eliminating
the associated profit on inputs purchased from related parties are acceptable.
Has your firm complied with the Commission’s instructions regarding costs associated with
inputs purchased from related parties?
Yes

No—Please contact Justin Jee (202-205-3186, [email protected]).

III-11. Nonrecurring charges.--For each annual and interim period for which financial results are
reported in question III-11, please indicate in the schedule below the specific nonrecurring
charges, the particular expense/cost line items from question III-11 where the associated charges
are included, a brief description of the charges, and the associated values (in $1,000).
Nonrecurring charges would include, but are not limited to, items such as asset write-offs and
accelerated depreciation due to restructuring of the company’s citric acid or certain citrate salts
operations.
Calendar ended-Item
Non-recurring charges: (In this column please
provide a brief description of each nonrecurring
charge and indicate the particular expense/cost line
items where the associated charges are included in
question III-11.)
1.
2.
3.
4.
5.
6.
7.

2006

2007

2008

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 16

PART III.--FINANCIAL INFORMATION--Continued
III-12a. Operations on Citric Acid and Certain Citrate Salts.--Report the revenue and related cost
information requested below on the citric acid and certain citrate salt operations of your U.S.
establishment(s).1 Do not report resales of products. Note that internal consumption and
transfers to related firms must be valued at fair market value and purchases from related firms
must be at cost.2 Provide data for your three most recently completed calendar years ended
December 31, in chronological order from left to right. If your firm was involved in tolling
operations (either as the toller or as the tollee) please contact Justin Jee at (202) 205-3186 before
completing this section of the questionnaire. Please note that tables III-12b, III-12c, and III-12d
are subsets of and should equal table III-12a. Be sure to reconcile these data with your responses
for question II-9.
Quantity (in 1,000 dry pounds) and value (in $1,000)
Calendar years ended-Item

2006

2007

2008

3

Net sales quantities:
Commercial sales

Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 17

PART III.--FINANCIAL INFORMATION--Continued
III-12b. Operations on Citric Acid.--Report the revenue and related cost information requested below on
the citric acid operations of your U.S. establishment(s).1 Do not report resales of products. Note that
internal consumption and transfers to related firms must be valued at fair market value and purchases
from related firms must be at cost.2 Provide data for your three most recently completed calendar years
ended December 31 in chronological order from left to right. If your firm was involved in tolling
operations (either as the toller or as the tollee) please contact Justin Jee at (202) 205-3186 before
completing this section of the questionnaire.
Calendar years ended-Item

2006

2007

2008

3

Net sales quantities:
Commercial sales

Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 18

PART III.--FINANCIAL INFORMATION--Continued
III-12c. Operations on Sodium Citrate.--Report the revenue and related cost information requested
below on the sodium citrate operations of your U.S. establishment(s).1 Do not report resales of products.
Note that internal consumption and transfers to related firms must be valued at fair market value and
purchases from related firms must be at cost.2 Provide data for your three most recently completed
calendar years ended December 31 in chronological order from left to right. If your firm was involved in
tolling operations (either as the toller or as the tollee) please contact Justin Jee at (202) 205-3186 before
completing this section of the questionnaire.
Calendar years ended-Item

2006

2007

2008

3

Net sales quantities:
Commercial sales

Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 19

PART III.--FINANCIAL INFORMATION--Continued
III-12d. Operations on Potassium Citrate.--Report the revenue and related cost information requested
below on the potassium citrate operations of your U.S. establishment(s).1 Do not report resales of
products. Note that internal consumption and transfers to related firms must be valued at fair market
value and purchases from related firms must be at cost.2 Provide data for your three most recently
completed calendar years ended December 31 in chronological order from left to right. If your firm was
involved in tolling operations (either as the toller or as the tollee) please contact Justin Jee at (202) 2053186 before completing this section of the questionnaire.

Calendar years ended-Item

2006

2007

2008

3

Net sales quantities:
Commercial sales

Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 20

PART III.--FINANCIAL INFORMATION--Continued
III-13. Asset values.--Report the total assets associated with the production, warehousing, and sale of
citric acid or certain citrate salts. If your firm does not maintain some or all of the specific asset data in
the normal course of business, please estimate it based upon some rational method (such as production,
sales, or costs) that is consistent with your cost allocations in the previous question. Provide data as of
the end of your three most recently completed calendar years ended December 31 in chronological order
from left to right.
Value (in $1,000)
Calendar years ended-Item

2006

2007

2008

Assets associated with the production,
warehousing, and sale of product:
1. Current assets:
A. Cash and equivalents
B. Accounts receivable, net
C. Inventories
D. All other current
E. Total current assets (lines 1.A. thru 1.D.)
2. Property, plant, and equipment (PPE)
A. Original cost of PPE
B. Less: Accumulated depreciation
C. Equals: Net book value of PPE
D. All other non-current
E. Total non-current (lines 2.C plus 2.D)
3. Total assets (add 1.E and 2.E)

III-14. Capital expenditures and research and development expenditures.--Report your firm’s capital
expenditures and research and development expenditures on citric acid or certain citrate salts.
Provide data for your three most recently completed calendar years in chronological order from
left to right.
Value (in $1,000)
Calendar years ended-Item
Capital expenditures
Research and development expenditures

2006

2007

2008

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 21

PART III.--FINANCIAL INFORMATION--Continued
III-15. Since January 1, 2006, has your firm experienced any actual negative effects on its return on
investment or its growth, investment, ability to raise capital, existing development and production
efforts (including efforts to develop a derivative or more advanced version of the product), or the
scale of capital investments as a result of imports of citric acid or certain citrate salts from Canada
or China?
No

Yes--My firm has experienced actual negative effects as follows:
Cancellation, postponement, or rejection of expansion projects
Denial or rejection of investment proposal
Reduction in the size of capital investments
Rejection of bank loans
Lowering of credit rating
Problem related to the issue of stocks or bonds
Other (specify)

III-16. Does your firm anticipate any negative impact of imports of citric acid or certain citrate salts from
Canada or China?

III-17. Does your firm use futures contracts to hedge against changes in the price of corn?
No

Yes—Please explain how your company accounts for gains and losses in
connection with these futures contracts. To what extent, if any, are
such gains or losses reflected in your costs of raw materials for
producing citric acid and certain citrate salts?

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 22

PART IV.--PRICING AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Amelia Preece (202-205-3250,
[email protected])
IV-1.

Who should be contacted regarding the requested pricing and related information?
Company contact:
Name and title
(
)
Phone number

E-mail address
PRICE DATA
This section requests quarterly quantity and value data on your firm’s U.S. commercial shipments to unrelated
parties of the following products that your firm produced during January 2006-December 2008:
NOTE.- All values and quantities should be reported on a dry-weight equivalent basis. For citric acid
only, dry weight prices should be expressed on an anhydrous equivalent basis.
Product 1.—Citric acid, granular, in dry form in 25 kilogram and 50 pound bags.
Product 2.—Citric acid, granular, in dry form packed in bulk sacks (“supersacks”).
Product 3.—Citric acid, in 48 to 52 percent solution form sold in bulk.
Product 4.—Sodium citrate, granular, in dry form in 25 kilogram and 50 pound bags.
Product 5.—Potassium citrate, granular, in dry form in 25 kilogram and 50 pound bags.
Please report sales on a delivered basis to your final customer, including U.S.-inland transportation
costs to your customer’s facility. Please note that total dollar values should reflect the FINAL NET
amount (i.e., should be net of all deductions for discounts or rebates). See instruction booklet.
Note:--Prices are requested separately for sales to end users and to distributors.
Note:--Prices of products 1, 2, and 3 are requested for sales on contract and spot sales separately.
Contract purchases are agreements, written or verbal, for multiple deliveries of product over a set
period of time.
Spot purchases are onetime delivery, usually made within 30 days of the purchase agreement.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 23

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-2.

Report below the quarterly price data1 for pricing products2 produced and sold by your firm.
(Quantity in 1,000 dry pounds, value in 1,000 dollars)
Product 1
Product 2
Spot sales
Contract sales
Spot sales
Contract sales
Quantity
Value
Quantity
Value
Quantity
Value
Quantity
Value
Sales to end users

2006
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
2007
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
2008
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
Product 1
Product 2
Spot sales
Contract sales
Spot sales
Contract sales
Quantity
Value
Quantity
Value
Quantity
Value
Quantity
Value
Sales to distributors
2006
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
2007
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
2008
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
1
Net delivered values (i.e., gross sales values less all discounts, including discounts on other supplied products,
promotional allowances, and transition allowances, allowances, rebates, prepaid freight, and the value of returned
goods), delivered to your customers’ U.S. facility (i.e., do include U.S-inland transportation costs).
2
Pricing product definitions are provided on the first page of Part IV.
Note.--If your product does not exactly meet the product specifications but is competitive with the specified product,
provide a description of your product:
Product 1:
Product 2:

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 24

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-2.

Report below the quarterly price data1 for pricing products2 produced and sold by your firm.
(Quantity in 1,000 dry pounds, value in 1,000 dollars)
Product 3 (dry equivalent)
Product 4
Spot sales
Contract sales
Spot and contract
Quantity
Value
Quantity
Value
Quantity
Value
Sales to end users

Product 5
Spot and contract
Quantity
Value

2006
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
2007
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
2008
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
Product 3 (dry equivalent)
Product 4
Spot sales
Contract sales
Spot and contract
Quantity
Value
Quantity
Value
Quantity
Value
Sales to distributors

Product 5
Spot and contract
Quantity
Value

2006
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
2007
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
2008
Jan.-Mar.
April-June
July-Sept.
Oct.-Dec.
1
Net delivered values (i.e., gross sales values less all discounts, including discounts on other supplied products,
promotional allowances, and transition allowances, allowances, rebates, prepaid freight, and the value of returned
goods), delivered to your customers’ U.S. facility (i.e., do include U.S-inland transportation costs).
2
Pricing product definitions are provided on the first page of Part IV.
Note.--If your product does not exactly meet the product specifications but is competitive with the specified product,
provide a description of your product:
Product 3:
Product 4:
Product 5:

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 25

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-3.

Please describe how your firm determines the prices that it charges for sales of citric acid and certain
citrate salts (transaction by transaction negotiation, contracts for multiple shipments, set price lists,
etc.). If your firm issues price lists, please include a copy of a recent price list with your submission.
If your price list is large, please submit sample pages.

IV-4.

Please describe your firm’s discount policy (quantity discounts, annual total volume discounts, etc.).

IV-5.

What are your firm’s typical sales terms for its U.S.-produced citric acid and certain citrate salts (e.g.,
2/10 net 30 days)?
. On what basis are your prices of such product usually
quoted
f.o.b.
, or delivered?

IV-6.

Approximately what shares of your firm’s sales of its U.S.-produced citric acid and certain citrate
salts in 2008 were on a (1) long-term contract basis (multiple deliveries for 12 months or more), (2)
short-term contract basis (multiple deliveries less than 12 months), and (3) spot sales basis (for a
single delivery)?
Type of sale

Share of sales (percent)

Long-term contracts
Short-term contracts
Spot sales
IV-7.

If you sell on a contract basis, what is the importance for your firm of the following factors on price at
the time of contract negotiations and how do each of these factors influence price?
a) Presence of product/bids from U.S. producers
Not important

Somewhat important

Very important

b) Competitive U.S. producers’ influence on price
Neutral

Downward

Upward

c) Presence of product/bids from Canadian producers
Not important

Somewhat important

Very important

d) Canadian producers’ influence on price
Neutral

Downward

Upward

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 26

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-7.

e) Presence of product/bids from Chinese producers
Not important

Somewhat important

Very important

f) Chinese producers’ influence on price
Neutral

Downward

Upward

g) Presence of product/bids from Nonsubject producers
Not important

Somewhat important

Very important

h) Nonsubject producers’ influence on price
Neutral
IV-8.

IV-9.

Downward

Upward

If you sell on a long-term contract basis, please answer the following questions with respect to
provisions of a typical long-term contract.
(a)

What is the average duration of a contract?

(b)

Can prices be renegotiated during the contract period?

(c)

Does the contract fix quantity, price, or both?

(d)

Does the contract have a meet or release provision?

(e)

Was the meet or release provision used?

(f)

When are contracts negotiated?
________________________________)
(Explain why.)
______________________________________________)

(g)

With whom do you make these contracts? End users

(h)

Industries of most important purchasers using these contracts

months
Yes

Quantity

No
Price

Yes

Yes

Both
No

No

percent Distributors

percent

______________

If you sell on a short-term contract basis, please answer the following questions with respect to
provisions of a typical short-term contract.
months

(a)

What is the average duration of a contract?

(b)

Can prices be renegotiated during the contract period?

(c)

Does the contract fix quantity, price, or both?

(d)

Does the contract have a meet or release provision?

(e)

Was the meet or release provision used?

(f)

When are contracts negotiated?
________________________________)
(Explain why.)
______________________________________________)

(g)

With whom do you make these contracts? End users

Yes

Quantity

Yes

No
Price

Yes

Both
No

No

percent Distributors

percent

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 27

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-9.

(h)

Industries of most important purchasers using these contracts

______________

IV-10. If you sell on a spot basis, please answer the following questions with respect to spot sales.
(a)

When do spot sales occur?
___________________________________________)
(Explain why.)
______________________________________________)

(b)

To whom do you make spot sales? End users

(c)

Industries of most important purchasers using these spot sales

(d)

How are terms set?

percent Distributors

percent

______________

__________________________________________

IV-11. If you sell on a spot basis, what is the importance for your firm of the following factors on price at the
time of contract negotiations and how do each of these factors influence price?
a) Presence of product/bids from U.S. producers
Not important

Somewhat important

Very important

b) Competitive U.S. producers’ influence on price
Neutral

Downward

Upward

c) Presence of product/bids from Canadian producers
Not important

Somewhat important

Very important

d) Canadian producers’ influence on price
Neutral

Downward

Upward

e) Presence of product/bids from Chinese producers
Not important

Somewhat important

Very important

f) Chinese producers’ influence on price
Neutral

Downward

Upward

g) Presence of product/bids from Nonsubject producers
Not important

Somewhat important

Very important

h) Nonsubject producers’ influence on price
Neutral

Downward

Upward

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 28

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-12. What is the average lead time between a customer’s order and the date of delivery for your firm’s
sales of your U.S.-produced citric acid and certain citrate salts?

Source

Share of sales,
2008

Lead time

From inventory

days

Produced to order

days

Total

IV-13. (a)

100 %

What is the approximate percentage of the total delivered cost of citric acid and certain citrate
salts that is accounted for by U.S. inland transportation costs?
percent.

(b)

Who generally arranges the transportation to your customers’ locations? (check one)
Your firm
purchaser

(c)

What proportion of your sales occur within 100 miles of your storage or production facility?
percent. Within 101 to 1,000 miles?
percent. Over 1,000 miles?
percent.

IV-14. What is the geographic market area in the United States served by your firm’s citric acid and certain
citrate salts? (check all that apply)
Northeast

Mid-Atlantic

Midwest

Southeast

Southwest

Rocky Mountains

West Coast

Northwest

National

Other (describe:

)

IV-15. Describe the end uses of the citric acid and certain citrate salts that you manufacture. For each enduse product, what percentage of the total cost is accounted for by citric acid and certain citrate salts?
End use

IV-16. (a)

Share of total cost (percent)

Can other products be substituted for citric acid and certain citrate salts?
No
(i)
(ii)
(iii)

Yes--Please list these substitute products in order of importance.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 29

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-16. (b)

For each possible substitute product, please give examples of applications and end uses for
which they are substitutes.

(c)

Have changes in the prices of these products affected the price for citric acid and certain
citrate salts?
No

Yes

IV-17. How has the demand within the United States (and outside the United States if known) for citric acid
and certain citrate salts changed since January 1, 2006? What principal factors affect changes in
demand?
Increased

No change

Decreased

IV-18. Have there been any significant changes in the product range or marketing of citric acid and certain
citrate salts since January 1, 2006?
No

Yes-- Please describe.

IV-19. Has your firm hedged against changes in the price of corn when you made contracts for the sale of
citric acid and certain citrate salts since January 1, 2006?
No

Yes

Please explain why you do or do not hedge when you make contracts for the sale of citric acid and
certain citrate salts.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 30

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-20. a) Has your firm used corn future prices in determining citric acid and certain citrate salts contract
prices since January 1, 2006?
No

Yes-- Please describe how future prices are used and why.

b) Have your contracts indexed citric acid and certain citrate salts prices based on the price of corn or
corn future prices since January 1, 2006?
No

Yes-- Please describe how.

IV-21. Has your firm allocated a certain portion of your sales of citric acid and certain citrate salts at year
end for annual contracts since January 1, 2006?
No

Yes--Please describe how your firm determines such allocations. Are the
allocations affected by purchasers’ reported requirement for citric acid and
certain citrate salts in the contract year?

IV-22. Has your firm ever limited the volume of citric acid and certain citrate salts that a single purchaser
may purchase in a year since January 1, 2006?
No

Yes—Why did you limit the volume purchased by individual purchasers? How
did you determine the volume each purchaser may buy?

IV-23. Has your firm placed purchasers on allocation or limited the amount of citric acid and certain citrate
salts they can purchase since January 1, 2006?
No

Yes--Please report the dates this occurred, the purchasers, and the reason for
limiting your sales.

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 31

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-24. Has your firm experienced any supply disruptions that affected your sales/shipments of citric acid and
certain citrate salts to purchasers since January 1, 2006?
No

Yes--Please report the dates this occurred, the purchasers, and the reason for
limiting your sales.

IV-25. Since January 1, 2006, have prices in the U.S. market for citric acid and certain citrate salts generally
increased, decreased, or stayed the same?
Increased

Decreased

Stayed the same

IV-26. If you checked “Increase” or “Decrease” in response to the previous question, please list (in order of
importance) what you believe are the principal reasons why prices changed.

IV-27. Are citric acid in anhydrous form, monohydrate form, dihydrate form, and in solution
interchangeable (i.e., can they physically be used in the same applications)? Please indicate below,
using “A” to indicate that the different forms of citric acid are always interchangeable, “F” to indicate
that the different forms of citric acid are frequently interchangeable, “S” to indicate that the forms of
citric acid are sometimes interchangeable, “N” to indicate that the different forms of citric acid are
never interchangeable, and “0” to indicate no familiarity with the forms of citric acid.1
Product form

Anhydrous

Monohydrate

Dihydrate

Solution

Anhydrous
Monohydrate
Dihydrate
1

For any forms of citric acid that are sometimes or never interchangeable, please explain the factors that
limit or preclude interchangeable use:

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 32

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-28. Are citric acid and certain citrate salts produced in the United States and in other countries
interchangeable (i.e., can they physically be used in the same applications)? Please indicate below,
using “A” to indicate that the products from a specified country-pair are always interchangeable, “F”
to indicate that the products are frequently interchangeable, “S” to indicate that the products are
sometimes interchangeable, “N” to indicate that the products are never interchangeable, and “0” to
indicate no familiarity with products from a specified country-pair.1

Country-pair

United States

Canada

China

Other countries, specify:
________________

United States
Canada
China
1

For any country-pair producing citric acid and certain citrate salts which is sometimes or never
interchangeable, please explain the factors that limit or preclude interchangeable use:

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 33

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-29. Are differences other than price (i.e., quality, availability, transportation network, product range,
technical support, etc.) between citric acid and certain citrate salts produced in the United States and
in other countries a significant factor in your firm’s sales of the products? Please indicate below,
using “A” to indicate that such differences are always significant, “F” to indicate that such differences
are frequently significant, “S” to indicate that such differences are sometimes significant, “N” to
indicate that such differences are never significant, and “0” to indicate no familiarity with products
from a specified country-pair.1

Country-pair

United States

Canada

China

Other countries, specify:
__________________

United States
Canada
China
1

For any country-pair for which factors other than price always or frequently are a significant factor in
your firm’s sales of citric acid and certain citrate salts, identify the country-pair and report the advantages
or disadvantages imparted by such factors:

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 34

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-30. Please identify below the names and addresses of your firm’s 10 largest customers for citric acid and
certain citrate salts during January 2006- December 2008. Please also provide the name and
telephone number of a contact person and the share of the quantity of your firm’s total shipments of
citric acid and certain citrate salts that each of these customers accounted for in 2008.

No.

1

2

3

4

5

6

7

8

9

10

Customer’s name

Street address (not P.O.
box), city, state, and zip
code

Contact person

Area
code and
telephone
number

Share of
2008
sales
(%)

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 35

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-31. COMPETITION FROM IMPORTS--LOST REVENUES.-- PLEASE DO NOT RE-SUBMIT
ALLEGATIONS PROVIDED IN THE PRELIMINARY PHASE OF THIS INVESTIGATION.
Since January 1, 2006: To avoid losing sales to competitors selling citric acid and certain citrate salts
from Canada or China, did your firm:
Reduce prices

No

Yes

Roll back announced price increases

No

Yes

If yes, please furnish as much of the following information as possible for each affected transaction.
Document such allegations of lost revenues whenever possible (documentation could include copies
of invoices, sales reports, or letters from customers). Please note that the Commission may contact
the firms named to verify the allegations reported.
Customer name, contact person, phone and fax numbers
Specific product(s) involved
Date of your initial price quotation
Quantity involved
Your initial rejected price quotation (total delivered value)
Your accepted price quotation (total delivered value)
The country of origin of the competing imported product
The competing price quotation of the imported product (total delivered value)
Customer name,
contact person,
phone and
Fax numbers

Product

Date of
quote

Quantity
(1,000 dry
pounds)

Initial rejected
U.S. price
(total value—
1,000 dollars)

Accepted
U.S. price
(total value—
1,000 dollars)

Country
of origin

Competing
import price
(total
value—1,000
dollars)

Business Proprietary
U.S. Producers’ Questionnaire - Citric Acid and Certain Citrate Salts

Page 36

PART IV.--PRICING AND RELATED INFORMATION--Continued
IV-32. COMPETITION FROM IMPORTS--LOST SALES.-- PLEASE DO NOT RE-SUBMIT
ALLEGATIONS PROVIDED IN THE PRELIMINARY PHASE OF THIS INVESTIGATION.
Since January 1, 2006: Did your firm lose sales of citric acid and certain citrate salts to imports of
these products from China or Canada?
No

Yes

If yes, please furnish as much of the following information as possible for each affected transaction.
Document such allegations of lost sales whenever possible (documentation could include copies of
invoices, sales reports, or letters from customers). Please note that the Commission may contact the
firms named to verify the allegations reported.
Customer name, contact person, phone and fax numbers
Specific product(s) involved
Date of your price quotation
Quantity involved
Your rejected price quotation (total delivered value)
The country of origin of the competing imported product
The accepted price quotation of the imported product (total delivered value)
Customer name,
contact person,
phone and
fax numbers

Product

Date of
quote

Quantity
(1,000 dry
pounds)

Rejected U.S.
price
(total value—
1,000 dollars)

Country of
origin

Competing
import price
(total value—
1,000 dollars)


File Typeapplication/pdf
File TitleMicrosoft Word - Producer.doc
Authorchris.cassise
File Modified2008-12-30
File Created2008-12-19

© 2024 OMB.report | Privacy Policy